Literature DB >> 6313371

Low renal uptake of 99mTc-DMSA in patients with proximal tubular dysfunction.

W H van Luÿk, G J Ensing, D A Piers.   

Abstract

In nine patients with different types of proximal tubulopathy and a nearly normal glomerular filtration rate a low uptake of 99mTc-DMSA in kidneys was found. The underlying mechanism seems to be an increased urinary excretion of 99mTc-DMSA. This radiopharmaceutical might be used as a marker of proximal tubular dysfunction.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6313371     DOI： 10.1007/bf00253217

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN： 0340-6997


  12 in total

1.  Clinical experience with 99mTc-DMSA (dimercaptosuccinic acid), a new renal-imaging agent.

Authors:  H Handmaker; B W Young; J M Lowenstein
Journal:  J Nucl Med       Date:  1975-01       Impact factor: 10.057

2.  A 99mTc-chelate substitute for organoradiomercurial renal agents.

Authors:  T H Lin; A Khentigan; H S Winchell
Journal:  J Nucl Med       Date:  1974-01       Impact factor: 10.057

3.  Renal cortical imaging in 35 patients: superior quality with 99mTc-DMSA.

Authors:  D Enlander; P M Weber; L V dos Remedios
Journal:  J Nucl Med       Date:  1974-09       Impact factor: 10.057

4.  The measurement of glomerular filtration rate with 125I-sodium iothalamate (Conray).

Authors:  C M Elwood; E M Sigman; C Treger
Journal:  Br J Radiol       Date:  1967-08       Impact factor: 3.039

5.  Biochemical studies of the renal radiopharmaceutical compound dimercaptosuccinate. I. Subcellular localization of 99mTc-DMS complex in the rat kidney in vivo.

Authors:  N Vanlić-Razumenić; J Petrović
Journal:  Eur J Nucl Med       Date:  1981-04

6.  Differential renal function using technetium-99m dimercapto-succinic acid (DMSA); in-vivo correlation.

Authors:  H Beekhuis; W H van Luyk; D A Piers
Journal:  J Nucl Med       Date:  1979-08       Impact factor: 10.057

7.  Optimal handling of dimercaptosuccinic acid for quantitative renal scanning.

Authors:  A Taylor; R L Lallone; P L Hagan
Journal:  J Nucl Med       Date:  1980-12       Impact factor: 10.057

Review 8.  Renal radiopharmaceuticals--an update.

Authors:  L R Chervu; M D Blaufox
Journal:  Semin Nucl Med       Date:  1982-07       Impact factor: 4.446

9.  Preparation of various Tc-99m dimercaptosuccinate complexes and their evaluation as radiotracers.

Authors:  I Ikeda; O Inoue; K Kurata
Journal:  J Nucl Med       Date:  1977-12       Impact factor: 10.057

10.  Tc-99m DMSA renal uptake: influence of biochemical and physiologic factors.

Authors:  C A Yee; H B Lee; M D Blaufox
Journal:  J Nucl Med       Date:  1981-12       Impact factor: 10.057
View more
  8 in total

Review 1.  Novel techniques and newer markers for the evaluation of "proximal tubular dysfunction".

Authors:  Michael Ludwig; Sidharth K Sethi
Journal:  Int Urol Nephrol       Date:  2011-03-01       Impact factor: 2.370

2.  Poor renal uptake of 99mtechnetium-dimercaptosuccinic acid and near-normal 99mtechnetium-mercaptoacetyltriglycine renogram in nephronophthisis.

Authors:  H Hecht; J Ohlsson; S A Starck
Journal:  Pediatr Nephrol       Date:  1996-04       Impact factor: 3.714

3.  Clinical and laboratory features of Macedonian children with OCRL mutations.

Authors:  Velibor Tasic; Vladimir J Lozanovski; Petar Korneti; Nadica Ristoska-Bojkovska; Vesna Sabolic-Avramovska; Zoran Gucev; Michael Ludwig
Journal:  Pediatr Nephrol       Date:  2011-01-20       Impact factor: 3.714

Review 4.  Nuclear medicine in the monitoring of organ function and the detection of injury related to cancer therapy.

Authors:  R A Valdés Olmos; C A Hoefnagel; J B van der Schoot
Journal:  Eur J Nucl Med       Date:  1993-06

5.  Decreased renal uptake of (99m)Tc-DMSA in patients with tubular proteinuria.

Authors:  Beom Hee Lee; So Hee Lee; Hyun Jin Choi; Hee Gyung Kang; So Won Oh; Dong Soo Lee; Il Soo Ha; Yong Choi; Hae Il Cheong
Journal:  Pediatr Nephrol       Date:  2009-07-05       Impact factor: 3.714

6.  Is the relative 99mTc-DMSA clearance a useful marker of proximal tubular dysfunction?

Authors:  W H van Luijk; G J Ensing; S Meijer; A J Donker; D A Piers
Journal:  Eur J Nucl Med       Date:  1984

7.  Technetium-99m dimercaptosuccinic acid and ifosfamide tubular dysfunction in children with cancer.

Authors:  J K Anninga; R A Valdés Olmos; J de Kraker; H van Tinteren; C A Hoefnagel; E A van Royen
Journal:  Eur J Nucl Med       Date:  1994-07

8.  L-Carnitine Protection Against Cisplatin Nephrotoxicity In Rats: Comparison with Amifostin Using Quantitative Renal Tc 99m DMSA Uptake.

Authors:  Yakup Yürekli; Perihan Unak; Ciğdem Yenisey; Türkan Ertay; Fazilet Zumrut Biber Müftüler; Emin İlker Medine
Journal:  Mol Imaging Radionucl Ther       Date:  2011-04-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.